Dissolving microneedle delivery of nanoparticle-encapsulated antigen elicits efficient cross-priming and th1 immune responses by murine langerhans cells

Journal of Investigative Dermatology

Volumn 135, Issue 2, 2015, Pages 425-434

  Zaric, Marija ^a   Lyubomska, Oksana ^a   Poux, Candice ^a   Hanna, Mary L ^a   McCrudden, Maeliosa T ^b   Malissen, Bernard ^c,d   Ingram, Rebecca J ^a   Power, Ultan F ^a   Scott, Christopher J ^b   Donnelly, Ryan F ^b   Kissenpfennig, Adrien ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD4 ANTIGEN; INTERLEUKIN 17; NANOPARTICLE; CD207 PROTEIN, MOUSE; LECTIN; MANNOSE BINDING LECTIN; MEMBRANE ANTIGEN; OVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CROSS PRESENTATION; EX VIVO STUDY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; IMMUNE RESPONSE; IN VIVO STUDY; LANGERHANS CELL; LYMPHOCYTE DIFFERENTIATION; MICRONEEDLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; ANIMAL; C57BL MOUSE; IMMUNIZATION; IMMUNOLOGY; SENDAI VIRUS; TH17 CELL;

ANIMALS; ANTIGENS; ANTIGENS, SURFACE; CD8-POSITIVE T-LYMPHOCYTES; CROSS-PRIMING; IMMUNIZATION; LANGERHANS CELLS; LECTINS, C-TYPE; MANNOSE-BINDING LECTINS; MICE; MICE, INBRED C57BL; NANOPARTICLES; OVALBUMIN; SENDAI VIRUS; TH1 CELLS; TH17 CELLS;

EID: 84925378659     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2014.415     Document Type: Article

References (44)

1. Bachy V, Hervouet C, Becker PD et al. (2013) Langerin negative dendritic cells promote potent CD8+ T-cell priming by skin delivery of live adenovirus vaccine microneedle arrays. Proc Natl Acad Sci USA 110:3041-6
2. Barnden MJ, Allison J, Heath WR et al. (1998) Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol 76:34-40
3. Bedoui S, Whitney PG, Waithman J et al. (2009) Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nat Immunol 10:488-95
4. Bobr A, Olvera-Gomez I, Igyarto BZ et al. (2010) Acute ablation of langerhans cells enhances skin immune responses. J Immunol 185:4724-8
5. Brewig N, Kissenpfennig A, Malissen B et al. (2009) Priming of CD8+ and CD4+ T cells in experimental leishmaniasis is initiated by different dendritic cell subtypes. J Immunol 182:774-83
6. Brown DM, Fisher TL, Wei C et al. (2001) Tumours can act as adjuvants for humoral immunity. Immunology 102:486-97
7. Bursch LS, Wang L, Igyarto B et al. (2007) Identification of a novel population of langerin + dendritic cells. J Exp Med 204:3147-56
8. Cheong C, Matos I, Choi JH et al. (2010) Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas. Cell 143:416-29
9. Donnelly RF, Majithiya R, Singh TR et al. (2011) Design, optimization and characterisation of polymeric microneedle arrays prepared by a novel laser-based micromoulding technique. Pharm Res 28:41-57
10. Duraisingham SS, Hornig J, Gotch F et al. (2009) TLR-stimulated CD34 stem cell-derived human skin-like and monocyte-derived dendritic cells fail to induce Th17 polarization of naive T cells but do stimulate Th1 and Th17 memory responses. J Immunol 183:2242-51
11. Elnekave M, Furmanov K, Shaul Y et al. (2014) Second-generation langerhans cells originating from epidermal precursors are essential for CD8+ T cell priming. J Immunol 192:1395-403
12. Fujita H, Nograles KE, Kikuchi T et al. (2009) Human langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production. Proc Natl Acad Sci USA 106:21795-800
13. Ginhoux F, Collin MP, Bogunovic M et al. (2007) Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state. J Exp Med 204:3133-46
14. Gutierro I, Hernandez RM, Igartua M et al. (2002) Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres. Vaccine 21:67-77
15. Hamdy S, Haddadi A, Hung RW et al. (2011) Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations. Adv Drug Deliv Rev 63:943-55
16. Hauser C, Snapper CM, Ohara J et al. (1989) T helper cells grown with hapte-nmodified cultured langerhans' cells produce interleukin 4 and stimulate IgE production by B cells. Eur J Immunol 19:245-51
17. Henri S, Guilliams M, Poulin LF et al. (2010) Disentangling the complexity of the skin dendritic cell network. Immunol Cell Biol 88:366-75
18. Henri S, Poulin LF, Tamoutounour S et al. (2010) CD207 + CD103 + dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of langerhans cells. J Exp Med 207:189-206
19. Hogquist KA, Jameson SC, Heath WR et al. (1994) T cell receptor antagonist peptides induce positive selection. Cell 76:17-27
20. Idoyaga J, Fiorese C, Zbytnuik L et al. (2013) Specialized role of migratory dendritic cells in peripheral tolerance induction. J Clin Invest 123:844-54
21. Igyarto BZ, Haley K, Ortner D et al. (2011) Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses. Immunity 35:260-72
22. Igyarto BZ, Kaplan DH (2013) Antigen presentation by langerhans cells. Curr Opin Immunol 25:115-9
23. Jaganathan KS, Vyas SP (2006) Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally. Vaccine 24:4201-11
24. Kautz-Neu K, Noordegraaf M, Dinges S et al. (2011) Langerhans cells are negative regulators of the anti-leishmania response. J Exp Med 208:885-91
25. Kim YC, Park JH, Prausnitz MR (2012) Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev 64:1547-68
26. Kissenpfennig A, Henri S, Dubois B et al. (2005) Dynamics and function of langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating langerhans cells. Immunity 22:643-54
27. Klechevsky E, Morita R, Liu M et al. (2008) Functional specializations of human epidermal langerhans cells and CD14+ dermal dendritic cells. Immunity 29:497-510
28. Mathers AR, Janelsins BM, Rubin JP et al. (2009) Differential capability of human cutaneous dendritic cell subsets to initiate Th17 responses. J Immunol 182:921-33
29. Meier O, Greber UF (2003) Adenovirus endocytosis. J Gene Med 5:451-62
30. Mollah SA, Dobrin JS, Feder RE et al. (2014) Flt3L dependence helps define an uncharacterized subset of murine cutaneous dendritic cells. J Invest Dermatol 134:1265-75
31. Poulin LF, Henri S, de Bovis B et al. (2007) The dermis contains langerin+ dendritic cells that develop and function independently of epidermal langerhans cells. J Exp Med 204:3119-31
32. Ritter U, Meissner A, Scheidig C et al. (2004) CD8 alpha- and langerin-negative dendritic cells, but not langerhans cells, act as principal antigenpresenting cells in leishmaniasis. Eur J Immunol 34:1542-50
33. Romani N, Brunner PM, Stingl G (2012) Changing views of the role of langerhans cells. J Invest Dermatol 132:872-81
34. Romani N, Thurnher M, Idoyaga J et al. (2010) Targeting of antigens to skin dendritic cells: possibilities to enhance vaccine efficacy. Immunol Cell Biol 88:424-30
35. Schwarz A, Noordegraaf M, Maeda A et al. (2010) Langerhans cells are required for UVR-induced immunosuppression. J Invest Dermatol 130:1419-27
36. Seneschal J, Jiang X, Kupper TS (2014) Langerin+ dermal DC, but not langerhans cells, are required for effective CD8-mediated immune responses after skin scarification with vaccinia virus. J Invest Dermatol 134:686-94
37. Sharp FA, Ruane D, Claass B et al. (2009) Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome. Proc Natl Acad Sci USA 106:870-5
38. Stoecklinger A, Eticha TD, Mesdaghi M et al. (2011) Langerin+ dermal dendritic cells are critical for CD8+ T cell activation and IgH gamma-1 class switching in response to gene gun vaccines. J Immunol 186:1377-83
39. Stoitzner P, Tripp CH, Eberhart A et al. (2006) Langerhans cells cross-present antigen derived from skin. Proc Natl Acad Sci USA 103:7783-8
40. Sullivan SP, Koutsonanos DG, Del Pilar Martin M et al. (2010) Dissolving polymer microneedle patches for influenza vaccination. Nat Med 16:915-20
41. Tamoutounour S, Guilliams M, Montanana Sanchis F et al. (2013) Origins and functional specialization of macrophages and of conventional and monocyte-derived dendritic cells in mouse skin. Immunity 39:925-38
42. Yang M, Hearnden CH, Oleszycka E et al. (2013) NLRP3 inflammasome activation and cytotoxicity induced by particulate adjuvants. Methods Mol Biol 1040:41-63
43. Zaric M, Lyubomska O, Touzelet O et al. (2013) Skin dendritic cell targeting via microneedle arrays laden with antigen-encapsulated poly-d,l-lactide-co-glycolide nanoparticles induces efficient antitumour and antiviral immune responses. ACS Nano 7:2042-55
44. Zhao X, Deak E, Soderberg K et al. (2003) Vaginal submucosal dendritic cells, but not langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J Exp Med 197:153-62